CS5 5mg*10vials

Cagrilintide + Semaglutide CS5 5mg*10vials

Cagrilintide + Semaglutide is a combination research peptide blend that pairs an amylin analog with a GLP-1 receptor agonist, designed for synergistic metabolic research.

The 5mg single-vial specification is the standard concentration, ideal for initial combination therapy studies, dose-response experiments, and researchers exploring dual-pathway metabolic regulation. This pre-mixed formulation eliminates the need for researchers to combine two separate peptides, ensuring consistent ratios across experimental groups.

Through dual pathway activation, this blend combines GLP-1 receptor signaling with amylin pathway modulation. This supports research into appetite regulation, glycemic control, and synergistic metabolic effects that go beyond either single compound alone.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for foundational combination therapy research and dual-pathway metabolic studies.